Everything you need to know about What Counts as a "Failed" Antidepressant Trial for TMS Coverage? — how it works, what it costs, and how to find a provider who actually knows what they're doing.
The TMS Patient Buyer's Guide
Everything to know before your first consult — questions to ask, what to expect, and how to compare providers.
A “failed” antidepressant trial, for TMS insurance purposes, is a medication you took at an adequate dose for an adequate length of time during your current depressive episode without enough improvement, or one you couldn’t tolerate because of side effects. Most plans want to see at least two such medications from different drug classes, but the exact number, the minimum duration and the paperwork they accept all vary by plan.
If you’ve been through several medications, you probably meet the idea behind the rule. The harder part is proving it on paper. This guide explains how plans define a trial and how to document yours.
Key takeaways
- The FDA clearance for TMS devices is broader than most insurance policies. Insurers add their own, stricter rules.
- Plans commonly ask for two antidepressants from different classes, but some ask for more, and some also ask for an augmentation trial or psychotherapy.
- “Adequate” usually means a standard dose for a minimum number of weeks. The minimum differs: the policies we reviewed use six weeks in some cases and eight in others.
- Stopping a drug because of side effects can count, if it’s documented.
- Records matter as much as history. Pharmacy fill records and prescriber notes carry the case.
The FDA label versus your insurer’s rules
TMS devices are FDA-cleared, not FDA-approved, which is a technical difference worth knowing. FDA’s 510(k) clearance for the NeuroStar system covers adults with major depressive disorder who have failed to receive satisfactory improvement from prior antidepressant medication in the current episode, as stated in the FDA clearance letter for a later NeuroStar update. The same document shows the system was later cleared for adolescents ages 15 to 21 as an adjunct treatment.
That is a low bar. Insurance policies are where the real requirements sit, and they’re written by each plan. So when someone says “you need to fail four meds,” that’s a plan rule, not a federal one.
What plans actually ask for
These are examples from published policies. They show the range, not a rule that applies to you.
| Source | Medication requirement (as written) |
|---|---|
| Louisiana Blue policy 00121 (effective March 2026) | Inadequate response to 2 antidepressants from 2 different classes, each tried for at least 6 weeks at generally accepted doses with at least 80% adherence; or inability to tolerate a therapeutic dose because of distinct side effects; or a history of response to TMS; or being an ECT candidate. Also asks for a failed trial of an effective psychotherapy. |
| Aetna Clinical Policy Bulletin 0469 | For adults, inadequate response to two antidepressants from different classes, each at a maximally tolerated labeled dose for at least 8 weeks, plus an augmentation trial of at least 8 weeks. |
| Medicare LCD L33398 (one of several regional Medicare policies) | No clinically significant response to adequate medication trials from at least two classes in the current episode, or intolerance shown by trials of agents with distinct side effects, plus a trial of evidence-based psychotherapy, among other pathways. |
| Humana Healthy Horizons (Louisiana Medicaid) | Lack of response to four trials from at least two classes, with at least two given as an adequate course of at least six weeks; or intolerance shown by trials of four agents. Also asks for a psychiatrist referral and prior ECT or a reason not to. |
Look at how different those are. One state Medicaid plan asks for four trials; the other policies ask for two. If you read a forum post saying “you need X,” check which plan the person had.
Key terms, decoded
“Trial”
A trial is one medication course, not one pill. Switching dose within the same drug is still one trial. Two drugs at once for the same period can count as separate trials in some policies and as one “combination” in others. The plan’s wording decides.
“Adequate dose”
Plans use phrases such as “generally accepted doses,” “standard therapeutic doses” or “maximally tolerated labeled dose.” Your prescriber’s notes should show that you were not on a token starter dose.
“Adequate duration”
The policies above range from six weeks to eight weeks. Your prescriber’s documentation should show start and stop dates, not just “tried it.”
“Different classes”
Louisiana Blue gives examples of classes: selective serotonin reuptake inhibitors, serotonin and norepinephrine reuptake inhibitors, tricyclic antidepressants, bupropion and mirtazapine. Two SSRIs would typically count as the same class, so sertraline followed by escitalopram usually wouldn’t meet a “two classes” rule on its own. Check how your plan defines it.
“Current episode”
Medication that failed during a previous episode, years ago, may not count. Aetna’s policy asks for trials in the current episode. If your episode has lasted years, that’s helpful. If you had a good stretch and then relapsed, your current episode might be shorter than you think, so talk to your psychiatrist about how it’s dated.
“Adherence”
Louisiana Blue asks for at least 80% adherence. If you skipped doses a lot, tell your prescriber so the record is honest. Pharmacy refill data is the usual evidence.
“Augmentation”
Adding a second medication (such as lithium or an atypical antipsychotic) to an antidepressant. Aetna asks for an augmentation trial in its adult criteria. Many other plans don’t.
When side effects count
If a medication caused side effects bad enough that you stopped, many plans treat that as meeting the medication requirement. The LCD summary and Louisiana Blue both name intolerance as a pathway. Some plans want more than one such trial, and some require the side effects to be distinct from one another.
For this to work, the record needs to say what happened. “Stopped due to nausea and insomnia at week 3” in your chart is far better than nothing. If a medication was stopped for a documented drug interaction with a medication you need, Humana’s Louisiana Medicaid policy lists that as a separate route.
Psychotherapy and ECT: the other boxes
The medication count isn’t the whole story. Several policies also look at:
- Psychotherapy. Louisiana Blue and the Medicare LCD both ask whether you tried an evidence-based therapy, without significant improvement on standardized scales. Aetna’s adult criteria don’t list it, though its adolescent criteria offer it as one option.
- ECT. Humana’s Louisiana Medicaid policy asks that ECT was tried, contraindicated or declined. Other policies don’t.
- Severity. Louisiana Blue asks for severe major depressive disorder documented by standardized rating scales. Our guide on tracking your PHQ-9 shows how those scores are used.
How to document your trials
Plan to bring this to your first consult. It will shorten the prior authorization request.
- Write a medication timeline. Drug, dose, start date, stop date, reason stopped.
- Ask for pharmacy records. Your pharmacy can print a history. If you’ve switched pharmacies, check each one.
- Request old records. Former prescribers and primary care offices may hold notes your current clinician doesn’t have.
- List therapy. Type, dates, frequency.
- Be specific about side effects. What happened, when, and who you told.
- Don’t guess. If you can’t remember, say so. Your clinic can fill gaps from records, and a made-up detail that contradicts a chart causes bigger problems than a gap.
Our TMS qualification checklist pairs well with this list, and the prior authorization walkthrough shows where your records end up.
If you don’t have enough trials on paper
You have options:
- Ask whether your plan has another pathway. Intolerance, prior TMS response and ECT-candidate routes exist in some policies.
- Ask your psychiatrist about the next reasonable trial. If a different class or an augmentation step makes clinical sense anyway, it may also close the paperwork gap. That’s a medical decision to make with your prescriber, not a way to game a rule.
- Ask about an exception. Some plans review unusual cases individually, particularly with a letter of medical necessity.
- Appeal if denied. See our appeals guide.
- Look at self-pay or financing. See our cost guide for how those pieces work.
What to do next
Take the candidate quiz for a quick read on where you stand, then find a TMS clinic in your area and ask their insurance coordinator which of your plan’s requirements are the sticking point. Your plan’s policy is public in many cases; searching your insurer’s name plus “transcranial magnetic stimulation medical policy” usually finds it.
Policies change. The quotes and numbers above are what we found in each source at the time of writing, so check your plan’s current version before you plan around any of it.
FAQ
How many antidepressants do I have to fail before TMS is covered?
It depends on your plan. Of the policies we reviewed, Louisiana Blue and Aetna ask for two from different classes, and one Louisiana Medicaid plan asks for four trials. Medicare policies differ by region. Check your plan’s written policy.
Does a medication I couldn’t tolerate count as a failed trial?
Often yes. Several policies include inability to tolerate medication as a pathway, but the side effects need to be documented, and some plans want more than one such trial.
Do two SSRIs count as two trials?
They can count as two trials in the sense of two courses, but not as two classes. If the policy requires two different classes, two SSRIs alone may not meet it.
Does psychotherapy count as a trial?
Some policies, including Louisiana Blue and the Medicare LCD we reviewed, require a trial of evidence-based psychotherapy as well as medication. Others don’t mention it for adults.
What if I can’t remember every medication I tried?
Ask your pharmacy and former prescribers for records. Your clinic can often reconstruct the timeline from them. Don’t estimate details you aren’t sure of.
Is the FDA label the same as the insurance requirement?
No. The FDA clearance language is broader. Insurance policies set their own criteria, which are usually stricter.
